Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
News Corp Class A
NWSA
$14.5B
| $123M | 0.02% |
4,918,328
+131,525
| +3% | +$3.26M |
|
|
PR
627
Permian Resources
PR
$17.9B
| $122M | 0.02% |
5,742,241
+273,016
| +5% | +$4.71M |
|
628
Hasbro
HAS
$12.6B
| $122M | 0.02% |
1,307,276
+27,351
| +2% | +$2.55M |
|
629
Tyler Technologies
TYL
$12.2B
| $122M | 0.02% |
356,575
+25,150
| +8% | +$9.36M |
|
630
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.59B
| $122M | 0.02% |
1,308,507
+62,980
| +5% | +$6.31M |
|
631
Generac Holdings
GNRC
$11.9B
| $122M | 0.02% |
624,283
+15,031
| +2% | +$2.89M |
|
632
Liberty Media Series C
FWONK
$24.3B
| $122M | 0.02% |
1,431,062
+98,004
| +7% | +$8.57M |
|
633
Stanley Black & Decker
SWK
$14.2B
| $121M | 0.02% |
1,698,376
+56,052
| +3% | +$4.5M |
|
|
SOLS
634
Solstice Advanced Materials
SOLS
$9.62B
| $120M | 0.02% |
1,575,971
-93,437
| -6% | -$6.4M |
|
635
Flowserve
FLS
$9.25B
| $120M | 0.02% |
1,632,534
+40,980
| +3% | +$3.25M |
|
636
Lumen
LUMN
$6.53B
| $119M | 0.02% |
17,175,568
-1,214,905
| -7% | -$9.2M |
|
637
Clorox
CLX
$11.6B
| $119M | 0.02% |
1,151,860
+43,191
| +4% | +$4.9M |
|
638
Masco
MAS
$16B
| $119M | 0.02% |
1,974,805
+27,032
| +1% | +$1.83M |
|
639
Brown & Brown
BRO
$22.9B
| $119M | 0.02% |
1,827,462
+73,886
| +4% | +$5.33M |
|
640
Neurocrine Biosciences
NBIX
$17.7B
| $119M | 0.02% |
902,788
+52,156
| +6% | +$6.92M |
|
|
GTLS
641
DELISTED
Chart Industries
GTLS
| $119M | 0.02% |
575,049
+14,116
| +3% | +$2.92M |
|
642
Ionis Pharmaceuticals
IONS
$9.35B
| $119M | 0.02% |
1,583,266
+41,425
| +3% | +$3.27M |
|
643
SPDR Gold MiniShares Trust
GLDM
$27.5B
| $119M | 0.02% |
1,282,254
-65,726
| -5% | -$6.34M |
|
644
APi Group
APG
$17.1B
| $119M | 0.02% |
2,931,883
+184,357
| +7% | +$7.82M |
|
645
Aptiv
APTV
$12B
| $117M | 0.02% |
1,688,062
+31,765
| +2% | +$2.45M |
|
646
Carlisle Companies
CSL
$13.6B
| $117M | 0.02% |
351,018
+7,680
| +2% | +$2.8M |
|
647
Rocket Companies
RKT
$36.9B
| $117M | 0.02% |
8,216,874
-329,058
| -4% | -$5.99M |
|
648
Tradeweb Markets
TW
$21.3B
| $116M | 0.02% |
989,492
+57,156
| +6% | +$6.54M |
|
649
TTM Technologies
TTMI
$13.6B
| $116M | 0.02% |
1,191,297
-235,606
| -17% | -$22.4M |
|
650
Everest Group
EG
$15.2B
| $116M | 0.02% |
354,804
+9,662
| +3% | +$3.18M |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.